Aurora Cannabis Inc (NAS:ACB)
$ 2.83 +0.10 (+3.85%) Market Cap: 174.19 Mil Enterprise Value: 108.24 Mil PE Ratio: 0 PB Ratio: 0.46 GF Score: 57/100

Q3 2026 Aurora Cannabis Inc Earnings Call Transcript

Feb 4, 2026 / 01:00 PM GMT
Release Date Price: $3.75 (-7.64%)

Key Points

Positve
  • Aurora Cannabis Inc (ACB) reported a 7% increase in net revenue, driven by a 12% growth in global medical cannabis revenue.
  • The company achieved a 100 basis point increase in adjusted gross margin, reaching 62%, with strong medical cannabis margins of 69%.
  • Aurora Cannabis Inc (ACB) generated positive free cash flow of $15.5 million and maintained a strong balance sheet with over $150 million in cash and no cannabis business-related debt.
  • The company is a market leader in the three largest nationally legal medical cannabis markets outside of Canada, with significant international revenue contributions.
  • Aurora Cannabis Inc (ACB) is focusing on exiting select lower-margin markets to prioritize higher-margin global medical cannabis business, which is expected to improve profitability.
Negative
  • Consumer cannabis net revenue decreased by 48% year-over-year, reflecting the company's strategic shift away from this segment.
  • The plant propagation segment experienced a decline in adjusted gross margin from 40% to 16% due to increased costs and inventory write-offs.
  • There is anticipated near-term pressure on sales and gross profit in the Australian market due to the shift towards premium products.
  • The company expects some one-time costs impacting cash flow in fiscal Q4 due to strategic market exits.
  • Aurora Cannabis Inc (ACB) faces price pressure in the German market due to increased competition, particularly in the value segment.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ACB.TO - Aurora Cannabis Inc
Q3 2026 Aurora Cannabis Inc Earnings Call
Feb 04, 2026 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to the Aurora Cannabis Inc. 3rd quarter 2026 results conference call. All participants will be in a listen-only mode, and a question-and-answer session will follow the formal presentation. This conference call is being recorded today, Wednesday, February 4, 2026. I would now like to turn the conference over to your host, Kevin Nellland, director of strategic finance and Investor relations. Please go ahead, sir.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Hello and thank you for joining us. With me is Miguel Martin, executive Chairman and CEO, and Simonna King
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot